Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 105 for “"Fusogenic"”.

  1. Fusogenic membrane glycoproteins as a gene therapy for cancer

    … This work tests the hypothesis that viral fusogenic membrane glycoproteins (FMG) have potential as cytotoxic gene therapy agents. The truncated, hyperfusogenic form of a C-type retrovirus envelope gene: the Gibbon ape leukaemia virus envelope (GALV), and the F and H genes of the …

    the-open-u Download PDF for Fusogenic membrane glycoproteins as a gene therapy for cancer (opens in a new tab)

  2. Biophysical and anticancer properties of mitoxantrone in programmable fusogenic vesicles

    This thesis characterizes programmable fusogenic vesicles (PFVs) and examines their usefulness as carriers for an anticancer drug. PFVs are cationic liposomes designed to exhibit time-dependent destabilization. They consist of non-bilayer-forming lipids that are stabilized into a bilayer by …

    ubc Repository record for Biophysical and anticancer properties of mitoxantrone in programmable fusogenic vesicles (opens in a new tab) Download PDF for Biophysical and anticancer properties of mitoxantrone in programmable fusogenic vesicles (opens in a new tab)

  3. THE USE OF FUSOGENIC LIPIDS AND HDAC6 INHIBITORS TO ENHANCE GENE DELIVERY

    There are growing studies with evidence that ex vivo genetic modifications of human cells, improve therapeutic potentials. Conventional viral vectors are favourable, but hindered by large-scale production issues. Currently, lentivirus production relies on transient transfection which are poor and …

    nus Repository record for THE USE OF FUSOGENIC LIPIDS AND HDAC6 INHIBITORS TO ENHANCE GENE DELIVERY (opens in a new tab) Download file for THE USE OF FUSOGENIC LIPIDS AND HDAC6 INHIBITORS TO ENHANCE GENE DELIVERY (opens in a new tab)

  4. Investigation of a fusogenic pH-sensitive liposomal system for tumour-targeted intracellular delivery of dinitrobenzamide mustard prodrugs

    … pPSL containing phosphatidylethanolamine are fusogenic and can achieve preferential cellular uptake, via endocytosis, and endosome escape to avoid lysosomal degradation enhancing its availability to DNA targets relative to DNBM prodrugs alone. Aim: The overall aim of this thesis was to …

    auckland-ms Repository record for Investigation of a fusogenic pH-sensitive liposomal system for tumour-targeted intracellular delivery of dinitrobenzamide mustard prodrugs (opens in a new tab)

  5. Phase-separated liposomes for efficient macromolecular delivery

    … However, a key shortcoming of existing fusogenic delivery systems is their inefficiency, requiring a high concentration of fusion-promoting lipids to cross cellular membrane barriers. To address this limitation, my work has explored the extent to which membrane fusion can be amplified …

    texas Repository record for Phase-separated liposomes for efficient macromolecular delivery (opens in a new tab)

  6. Exploring Novel Methods to Express Cytotoxic Proteins from Oncolytic Adenoviral Vectors

    … local tumor cell killing is to arm vectors with fusogenic proteins, which promote cell-cell fusion and extend cytopathic effects beyond initially infected cells. Fusion-associated small transmembrane (FAST) proteins are small, non-structural fusogenic proteins encoded by fusogenic reoviruses and …

    ottawa-retro Repository record for Exploring Novel Methods to Express Cytotoxic Proteins from Oncolytic Adenoviral Vectors (opens in a new tab)

  7. Novel Peptide Biomaterials for Enhanced Delivery of siRNA Cargo for Treatment of Ovarian Cancer

    … and can deliver siRNA cargo intracellularly. Fusogenic peptides, cell penetrating peptides, and targeting peptides can all be used as systems to complex with and deliver siRNA cargo. This work developed a tandem peptide system, comprised of fusogenic and targeting peptide regions, to …

    clemson Repository record for Novel Peptide Biomaterials for Enhanced Delivery of siRNA Cargo for Treatment of Ovarian Cancer (opens in a new tab)

  8. Understanding the Role of Loner in Myoblast Fusion

    … Previous studies have revealed an asymmetric "fusogenic synapse", wherein the FCM generates an F-actin-enriched podosome-like structure (PLS) to invade the founder cell to promote cell membrane fusion. Previous work from our lab identified a Sec7 and PH domain-containing guanine nucleotide …

    utswmed Repository record for Understanding the Role of Loner in Myoblast Fusion (opens in a new tab) Embargoed until 2028-08-01

  9. Requirements for syncytium formation mediated by the fusion glycoprotein of human parainfluenza virus type 3.

    … were immunizers from VF-infected cell lysates. Fusogenic activity of the F protein was demonstrated only upon coinfection of HeLa T4$\sp+$ cells with VF + VHN and resulted in syncytium formation and hemolysis. Recombinant adenoviruses AdF and AdHN, expressed the HPIV3 F and HN proteins on the …

    ottawa-retro Repository record for Requirements for syncytium formation mediated by the fusion glycoprotein of human parainfluenza virus type 3. (opens in a new tab)

  10. The Role of Dynamin in Cell-Cell Fusion

    … with multiple finger-like protrusions at the fusogenic synapse. Here, we shown that the conserved large GTPase Dynamin (Dyn), best known for its function in endocytosis, is a critical component of myoblast fusion in vivo. Interference with Dyn function during myoblast fusion using two …

    jhu Repository record for The Role of Dynamin in Cell-Cell Fusion (opens in a new tab)

  11. The Pivotal Role of cGAS in Host Defense Against Mycobacterium Tuberculosis and in Particle-Induced Immunity

    … autophagy. Previous studies revealed that some fusogenic liposomes and enveloped virus-like particles can activate type I interferons. Here we have shown that fusogenic liposomes and nonenveloped virus-like particles can activate the cGAS pathway and trigger interferon production, which is …

    utswmed Repository record for The Pivotal Role of cGAS in Host Defense Against Mycobacterium Tuberculosis and in Particle-Induced Immunity (opens in a new tab)

  12. Disrupt and deliver: towards an ultrasound-sensitive lipid-based drug delivery system against biofilm infections

    … loaded into cationic (positively-charged) or fusogenic (membrane fusing) liposomes and evaluated against planktonic (free-swimming) and biofilm models of E. coli and E. faecalis. For the VAN-loaded liposomes, the cationic formulation was of comparable efficacy to free VAN against both E. coli …

    oxford Repository record for Disrupt and deliver: towards an ultrasound-sensitive lipid-based drug delivery system against biofilm infections (opens in a new tab)

  13. Improving Adenovirus Efficacy with p14 Fusion Associated Small Transmembrane Protein Expression for Cancer Treatment

    … Ad does not spread within a tumor well. As such, fusogenic proteins have been incorporated into these vectors in an attempt to improve spread through cell-cell fusion. Fusogenic protein mediated cell fusion is also associated with syncytiosome release and cell death, which promote an immune …

    ottawa-retro Repository record for Improving Adenovirus Efficacy with p14 Fusion Associated Small Transmembrane Protein Expression for Cancer Treatment (opens in a new tab)

  14. THE ROLE OF ADP RIBOSYLATION FACTOR GTPASES IN MYOBLAST FUSION IN DROSOPHILA

    … active Arf6. All tested Arfs localized to the fusogenic synapse in cultured cells, while Arf6 localized to the fusogenic synapse in embryos, but not Arf1 and Arf4. Therefore, Arf1 and Arf6 appear to have redundant functions in myoblast fusion. This broad study of several Arfs lays the …

    jhu Repository record for THE ROLE OF ADP RIBOSYLATION FACTOR GTPASES IN MYOBLAST FUSION IN DROSOPHILA (opens in a new tab)

  15. Novel Oncolytic Herpesviruses for Breast Cancer Treatment

    … of previously reported agents, new oncolytic and fusogenic HSV-1 OncSyn and OncdSyn viruses were constructed based on wild type HSV-1 (F) strain. To provide for safety and tumor selectivity, the viruses carried a large deletion including one of the two ¦Ã134.5 genes. The ¦Ã134.5 gene, a major …

    lsu-thes Repository record for Novel Oncolytic Herpesviruses for Breast Cancer Treatment (opens in a new tab)

  16. Multifunctional Peptides to Improve Nucleic Acid Delivery for Ovarian Cancer Treatment

    … Our lab has previously designed a novel fusogenic peptide sequence capable of delivering siRNA to ovarian tumors in vivo. Despite its success in delivering siRNA intratumorally, regional delivery via intraperitoneal (IP) injections was modest. Therefore, this work developed and …

    clemson Repository record for Multifunctional Peptides to Improve Nucleic Acid Delivery for Ovarian Cancer Treatment (opens in a new tab)

  17. Etude expérimentale du peptide oblique de l’α-synucléine

    … effect of these proteins. Thanks to their fusogenic properties, they could interact directly with the membrane leading to cell death. Tilted peptides could also be involved in the tranconformational process of these proteins. The aim of this study was to characterise experimentally the …

    liege Repository record for Etude expérimentale du peptide oblique de l’α-synucléine (opens in a new tab) Download PDF for Etude expérimentale du peptide oblique de l’α-synucléine (opens in a new tab)

  18. DNA-triggered release liposomes : a pharmaceutical strategy for improving the tumor exposure of chemotherapeutic agents

    … at the tumor. With the well-known propensity of fusogenic cationic liposomes to associate with DNA and strong evidences indicating selective localization of extracellular DNA in solid tumors, it is hypothesized that a fusogenic cationic liposome formulation containing DOTAP and DOPE would exhibit …

    ubc Repository record for DNA-triggered release liposomes : a pharmaceutical strategy for improving the tumor exposure of chemotherapeutic agents (opens in a new tab) Download PDF for DNA-triggered release liposomes : a pharmaceutical strategy for improving the tumor exposure of chemotherapeutic agents (opens in a new tab)

  19. In-vitro investigation of reversible siRNA-poly(polyethylene glycol-acrylate) conjugates

    … agents, lipofectamine™ RNAiMAX or the fusogenic peptide KALA to enhance their transfection efficiency. A CelITiter-Blue®Cell viability assay showed that the conjugates and their complexes (except the lipofectamine complex ofthe HMWC) did not have a significant effect on the viability of …

    unsw Repository record for In-vitro investigation of reversible siRNA-poly(polyethylene glycol-acrylate) conjugates (opens in a new tab)

Page 1 of 6